Logo image of QDEL

QUIDELORTHO CORP (QDEL) Stock Fundamental Analysis

NASDAQ:QDEL - Nasdaq - US2197981051 - Common Stock - Currency: USD

40.46  -0.57 (-1.39%)

After market: 40.46 0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to QDEL. QDEL was compared to 190 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of QDEL have multiple concerns. QDEL is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year QDEL was profitable.
QDEL had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: QDEL reported negative net income in multiple years.
QDEL had a positive operating cash flow in 4 of the past 5 years.
QDEL Yearly Net Income VS EBIT VS OCF VS FCFQDEL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B

1.2 Ratios

QDEL has a Return On Assets of -27.45%. This is comparable to the rest of the industry: QDEL outperforms 46.28% of its industry peers.
QDEL has a Return On Equity (-58.57%) which is in line with its industry peers.
QDEL has a better Return On Invested Capital (1.42%) than 69.15% of its industry peers.
The Average Return On Invested Capital over the past 3 years for QDEL is below the industry average of 8.19%.
Industry RankSector Rank
ROA -27.45%
ROE -58.57%
ROIC 1.42%
ROA(3y)-8.45%
ROA(5y)9.38%
ROE(3y)-18.81%
ROE(5y)8.17%
ROIC(3y)4.37%
ROIC(5y)20.45%
QDEL Yearly ROA, ROE, ROICQDEL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

1.3 Margins

The Operating Margin of QDEL (3.68%) is better than 70.21% of its industry peers.
In the last couple of years the Operating Margin of QDEL has declined.
QDEL has a Gross Margin of 47.62%. This is in the lower half of the industry: QDEL underperforms 60.11% of its industry peers.
In the last couple of years the Gross Margin of QDEL has declined.
Industry RankSector Rank
OM 3.68%
PM (TTM) N/A
GM 47.62%
OM growth 3Y-68.75%
OM growth 5Y-39.02%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.83%
GM growth 5Y-5.07%
QDEL Yearly Profit, Operating, Gross MarginsQDEL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

1

2. Health

2.1 Basic Checks

QDEL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for QDEL has been increased compared to 1 year ago.
QDEL has more shares outstanding than it did 5 years ago.
QDEL has a worse debt/assets ratio than last year.
QDEL Yearly Shares OutstandingQDEL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
QDEL Yearly Total Debt VS Total AssetsQDEL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

Based on the Altman-Z score of 1.05, we must say that QDEL is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of QDEL (1.05) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.68 indicates that QDEL is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.68, QDEL is doing worse than 69.68% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF N/A
Altman-Z 1.05
ROIC/WACC0.17
WACC8.31%
QDEL Yearly LT Debt VS Equity VS FCFQDEL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

A Current Ratio of 1.38 indicates that QDEL should not have too much problems paying its short term obligations.
With a Current ratio value of 1.38, QDEL is not doing good in the industry: 80.32% of the companies in the same industry are doing better.
QDEL has a Quick Ratio of 1.38. This is a bad value and indicates that QDEL is not financially healthy enough and could expect problems in meeting its short term obligations.
QDEL has a worse Quick ratio (0.81) than 87.77% of its industry peers.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 0.81
QDEL Yearly Current Assets VS Current LiabilitesQDEL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

5

3. Growth

3.1 Past

The earnings per share for QDEL have decreased strongly by -55.21% in the last year.
The Earnings Per Share has been decreasing by -9.03% on average over the past years.
Looking at the last year, QDEL shows a decrease in Revenue. The Revenue has decreased by -7.17% in the last year.
Measured over the past years, QDEL shows a very strong growth in Revenue. The Revenue has been growing by 39.07% on average per year.
EPS 1Y (TTM)-55.21%
EPS 3Y-52.97%
EPS 5Y-9.03%
EPS Q2Q%-46.15%
Revenue 1Y (TTM)-7.17%
Revenue growth 3Y17.89%
Revenue growth 5Y39.07%
Sales Q2Q%-4.69%

3.2 Future

The Earnings Per Share is expected to grow by 34.83% on average over the next years. This is a very strong growth
Based on estimates for the next years, QDEL will show a small growth in Revenue. The Revenue will grow by 4.04% on average per year.
EPS Next Y31.99%
EPS Next 2Y35.02%
EPS Next 3Y34.83%
EPS Next 5YN/A
Revenue Next Year0.53%
Revenue Next 2Y2.37%
Revenue Next 3Y4.04%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
QDEL Yearly Revenue VS EstimatesQDEL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
QDEL Yearly EPS VS EstimatesQDEL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 5 10 15

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 21.87, QDEL is valued on the expensive side.
Based on the Price/Earnings ratio, QDEL is valued cheaply inside the industry as 84.04% of the companies are valued more expensively.
QDEL's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 29.63.
QDEL is valuated correctly with a Price/Forward Earnings ratio of 16.57.
86.17% of the companies in the same industry are more expensive than QDEL, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.68, QDEL is valued a bit cheaper.
Industry RankSector Rank
PE 21.87
Fwd PE 16.57
QDEL Price Earnings VS Forward Price EarningsQDEL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, QDEL is valued cheaper than 95.21% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.11
QDEL Per share dataQDEL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

QDEL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as QDEL's earnings are expected to grow with 34.83% in the coming years.
PEG (NY)0.68
PEG (5Y)N/A
EPS Next 2Y35.02%
EPS Next 3Y34.83%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for QDEL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

QUIDELORTHO CORP

NASDAQ:QDEL (2/21/2025, 8:00:01 PM)

After market: 40.46 0 (0%)

40.46

-0.57 (-1.39%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-12 2025-02-12/amc
Earnings (Next)N/A N/A
Inst Owners109.74%
Inst Owner Change3.7%
Ins Owners0.49%
Ins Owner Change0.3%
Market Cap2.72B
Analysts76
Price Target54.5 (34.7%)
Short Float %5.15%
Short Ratio3.71
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)116.37%
Min EPS beat(2)70.58%
Max EPS beat(2)162.15%
EPS beat(4)3
Avg EPS beat(4)49.79%
Min EPS beat(4)-43.99%
Max EPS beat(4)162.15%
EPS beat(8)6
Avg EPS beat(8)34.67%
EPS beat(12)9
Avg EPS beat(12)37.28%
EPS beat(16)11
Avg EPS beat(16)28.49%
Revenue beat(2)2
Avg Revenue beat(2)6.4%
Min Revenue beat(2)1.79%
Max Revenue beat(2)11.02%
Revenue beat(4)3
Avg Revenue beat(4)1.18%
Min Revenue beat(4)-8.64%
Max Revenue beat(4)11.02%
Revenue beat(8)7
Avg Revenue beat(8)3.13%
Revenue beat(12)10
Avg Revenue beat(12)3.67%
Revenue beat(16)11
Avg Revenue beat(16)4.11%
PT rev (1m)0.54%
PT rev (3m)-4.87%
EPS NQ rev (1m)0.56%
EPS NQ rev (3m)-43.38%
EPS NY rev (1m)-3.27%
EPS NY rev (3m)-18.38%
Revenue NQ rev (1m)0.06%
Revenue NQ rev (3m)-3.23%
Revenue NY rev (1m)0.99%
Revenue NY rev (3m)2.01%
Valuation
Industry RankSector Rank
PE 21.87
Fwd PE 16.57
P/S 0.97
P/FCF N/A
P/OCF 27.3
P/B 0.85
P/tB N/A
EV/EBITDA 9.11
EPS(TTM)1.85
EY4.57%
EPS(NY)2.44
Fwd EY6.04%
FCF(TTM)-1.44
FCFYN/A
OCF(TTM)1.48
OCFY3.66%
SpS41.89
BVpS47.38
TBVpS-5.65
PEG (NY)0.68
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -27.45%
ROE -58.57%
ROCE 1.8%
ROIC 1.42%
ROICexc 1.46%
ROICexgc 3.97%
OM 3.68%
PM (TTM) N/A
GM 47.62%
FCFM N/A
ROA(3y)-8.45%
ROA(5y)9.38%
ROE(3y)-18.81%
ROE(5y)8.17%
ROIC(3y)4.37%
ROIC(5y)20.45%
ROICexc(3y)4.54%
ROICexc(5y)30.14%
ROICexgc(3y)17.28%
ROICexgc(5y)56.28%
ROCE(3y)5.53%
ROCE(5y)25.88%
ROICexcg growth 3Y-72.22%
ROICexcg growth 5Y-43.99%
ROICexc growth 3Y-77.14%
ROICexc growth 5Y-43.03%
OM growth 3Y-68.75%
OM growth 5Y-39.02%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.83%
GM growth 5Y-5.07%
F-Score3
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF N/A
Debt/EBITDA 3.86
Cap/Depr 42.76%
Cap/Sales 6.97%
Interest Coverage 250
Cash Conversion 17.7%
Profit Quality N/A
Current Ratio 1.38
Quick Ratio 0.81
Altman-Z 1.05
F-Score3
WACC8.31%
ROIC/WACC0.17
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-55.21%
EPS 3Y-52.97%
EPS 5Y-9.03%
EPS Q2Q%-46.15%
EPS Next Y31.99%
EPS Next 2Y35.02%
EPS Next 3Y34.83%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.17%
Revenue growth 3Y17.89%
Revenue growth 5Y39.07%
Sales Q2Q%-4.69%
Revenue Next Year0.53%
Revenue Next 2Y2.37%
Revenue Next 3Y4.04%
Revenue Next 5YN/A
EBIT growth 1Y-64.52%
EBIT growth 3Y-63.16%
EBIT growth 5Y-15.19%
EBIT Next Year935.01%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-165.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-73%
OCF growth 3YN/A
OCF growth 5YN/A